GGrantIndex
← Leaderboards

Edward W. Gabrielson

Johns Hopkins University

$7,965,645
Attributed
$7,965,645
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$7,965,645 · 11

By mechanism

P50$2,384,860 · 4
T32$2,329,198 · 1
P30$1,666,200 · 3
R01$1,463,241 · 1
R21$122,146 · 1
U54$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Human Tissue

Research focus

Human TissueImmunocytochemistryMalignant NeoplasmsMolecularCancer PatientSpecimenLaboratoriesResponseCancer Cell LineXenograft ProcedurePublic Health Medicine (Field)Malignant Neoplasm Of LungClinical ResearchBiologicalCancer Registry /ResourceBiomedical FacilityPathologyLung NeoplasmsBreast NeoplasmsLungImageBaseCancer CellBiopsy

Grant awards (36)

Rapid Autopsy$178,637
P30 · FY2021 · CA · contact PI
CB: Human Tissue and Pathology$281,281
P50 · FY2013 · CA · contact PI
P4: Inhibition of Fatty Acid Synthase for Lung Cancer Treatment$169,748
P50 · FY2013 · CA · contact PI
CB: Human Tissue and Pathology$243,288
P50 · FY2012 · CA · contact PI
P4: Inhibition of Fatty Acid Synthase for Lung Cancer Treatment$143,481
P50 · FY2012 · CA · contact PI
Training Program in the Pathobiology of Cancer$400,129
T32 · FY2011 · CA · contact PI
CB: Human Tissue and Pathology$262,619
P50 · FY2011 · CA · contact PI
P4: Inhibition of Fatty Acid Synthase for Lung Cancer Treatment$158,168
P50 · FY2011 · CA · contact PI
Training Program in the Pathobiology of Cancer$421,597
T32 · FY2010 · CA · contact PI
CB: Human Tissue and Pathology$245,983
P50 · FY2010 · CA · contact PI
P4: Inhibition of Fatty Acid Synthase for Lung Cancer Treatment$148,146
P50 · FY2010 · CA · contact PI
Training Program in the Pathobiology of Cancer$409,541
T32 · FY2009 · CA · contact PI
CB: Human Tissue and Pathology$374,801
P50 · FY2009 · CA · contact PI
P4: Inhibition of Fatty Acid Synthase for Lung Cancer Treatment$225,731
P50 · FY2009 · CA · contact PI
Training Program in the Pathobiology of Cancer$410,971
T32 · FY2008 · CA · contact PI
Training Program in the Pathobiology of Cancer$272,366
T32 · FY2007 · CA · contact PI
A Metabolic Target for Lung Cancer Prevention$553,797
R01 · FY2005 · CA
TRAINING PROGRAM IN THE PATHOBIOLOGY OF CANCER$414,594
T32 · FY2005 · CA
A Metabolic Target for Lung Cancer Prevention$541,569
R01 · FY2004 · CA
A Metabolic Target for Lung Cancer Prevention$367,875
R01 · FY2003 · CA
Core--Specimen Procurement and Pathology Facility$250,404
P30 · FY2002 · CA
Core--Specimen Procurement and Pathology Facility$250,404
P30 · FY2002 · CA
MOLECULAR PHENOTYPES OF BREAST CANCER$0
P50 · FY2002 · CA
Pilot--Tumor aggressiveness retated to centrosome defects$0
U54 · FY2002 · CA
CORE--TISSUE RESOURCES$0
P50 · FY2002 · CA
Core--Specimen Procurement and Pathology Facility$250,404
P30 · FY2001 · CA
Core--Specimen Procurement and Pathology Facility$250,404
P30 · FY2001 · CA
Pilot--Tumor aggressiveness retated to centrosome defects$0
U54 · FY2001 · CA
MOLECULAR PHENOTYPES OF BREAST CANCER$0
P50 · FY2001 · CA
CORE--TISSUE RESOURCES$0
P50 · FY2001 · CA
Core--Specimen Procurement and Pathology Facility$0
P30 · FY2001 · CA
CORE--HUMAN TISSUE AND PATHOLOGY FACILITY$296,752
P30 · FY2000 · CA
CORE--HUMAN TISSUE AND PATHOLOGY FACILITY$189,195
P30 · FY2000 · CA
CORE--TISSUE RESOURCES$131,614
P50 · FY2000 · CA
MICROSATELLITE MARKERS OF DCIS PROGNOSIS$122,146
R21 · FY2000 · CA
MOLECULAR PHENOTYPES OF BREAST CANCER$0
P50 · FY2000 · CA